NPI: 1114167145 · KLAMATH FALLS, OR 97603 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/04/2009
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/04/2009 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 3,794 | $51K |
| 2020 | 17,078 | $249K |
| 2021 | 15,859 | $209K |
| 2022 | 16,399 | $242K |
| 2023 | 14,716 | $281K |
| 2024 | 4,535 | $155K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 23,754 | 1,538 | $1.12M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 18,670 | 839 | $56K |
| A4657 | Syringe, with or without needle, each | 5,557 | 1,435 | $5K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 669 | 273 | $3K |
| J1756 | Injection, iron sucrose, 1 mg | 6,008 | 1,098 | $2K |
| J1270 | Injection, doxercalciferol, 1 mcg | 8,071 | 608 | $722.09 |
| 90674 | 86 | 71 | $371.20 | |
| 83540 | 1,511 | 868 | $0.00 | |
| 85048 | 1,528 | 887 | $0.00 | |
| 83970 | 1,083 | 625 | $0.00 | |
| 85041 | 1,529 | 887 | $0.00 | |
| 82108 | 122 | 64 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 140 | 12 | $0.00 |
| 82728 | 1,508 | 868 | $0.00 | |
| 83550 | 1,060 | 651 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 971 | 474 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 114 | 95 | $0.00 |